0001209191-18-041768.txt : 20180705
0001209191-18-041768.hdr.sgml : 20180705
20180705183426
ACCESSION NUMBER: 0001209191-18-041768
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180705
DATE AS OF CHANGE: 20180705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patterson Matthew R
CENTRAL INDEX KEY: 0001401018
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37833
FILM NUMBER: 18941498
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Audentes Therapeutics, Inc.
CENTRAL INDEX KEY: 0001628738
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461606174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 415-638-6556
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-02
0
0001628738
Audentes Therapeutics, Inc.
BOLD
0001401018
Patterson Matthew R
C/O AUDENTES THERAPEUTICS, INC.
600 CALIFORNIA STREET, 17TH FLOOR
SAN FRANCISCO
CA
94108
1
1
0
0
Chief Executive Officer
Common Stock
2018-07-02
4
M
0
19599
0.78
A
19599
D
Common Stock
2018-07-02
4
S
0
19599
38.3282
D
0
D
Common Stock
2018-07-02
4
M
0
1401
0.78
A
1401
D
Common Stock
2018-07-02
4
S
0
1401
38.7793
D
0
D
Common Stock
2018-07-03
4
M
0
26901
0.78
A
26901
D
Common Stock
2018-07-03
4
S
0
26901
40.0528
D
0
D
Common Stock
2018-07-05
4
M
0
23147
0.78
A
23147
D
Common Stock
2018-07-05
4
S
0
23147
40.042
D
0
D
Common Stock
171814
I
By Matthew R. Patterson Revocable Trust
Stock Option (right to buy)
0.78
2018-07-02
4
M
0
19599
0.00
D
2023-09-25
Common Stock
19599
159151
D
Stock Option (right to buy)
0.78
2018-07-02
4
M
0
1401
0.00
D
2023-09-25
Common Stock
1401
157750
D
Stock Option (right to buy)
0.78
2018-07-03
4
M
0
26901
0.00
D
2023-09-25
Common Stock
26901
130849
D
Stock Option (right to buy)
0.78
2018-07-05
4
M
0
23147
0.00
D
2023-09-25
Common Stock
23147
107702
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
Represents the weighted average sale price. The lowest price at which shares were sold was $37.71 and the highest price at which shares were sold was $38.71. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes 2, 3, 4 and 5 to this Form 4.
Represents the weighted average sale price. The lowest price at which shares were sold was $38.72 and the highest price at which shares were sold was $38.99.
Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.55.
Represents the weighted average sale price. The lowest price at which shares were sold was $40.00 and the highest price at which shares were sold was $40.17.
The reporting person is the trustee of the Matthew R. Patterson Revocable Trust.
The option vested as to 25% of the total shares on January 1, 2014, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on January 1, 2017, subject to the reporting person's provision of service to the issuer on each vesting date and to accelerated vesting in the event of the occurrence of certain events.
/s/ Thomas Soloway as attorney-in-fact for Matthew Patterson
2018-07-05